EKE.A. Kiselnikova

E.A. Kiselnikova

*This is an algorithmically generated author record based on publicly available information.

E.A. Kiselnikova has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Bioimpedance analysis parameters and metabolic profile in children with non-alcoholic fatty liver disease

    by A.м. Yakubovich, E.V. Pavlovskaya, M.E. Bagaeva, A.I. Zubovich, E.A. Kiselnikova, I.V. Vorozhko, T.V. Strokova

    Показатели биоимпедансного анализа и метаболический профиль у детей при неалкогольной жировой болезни печени

  • Association between breastfeeding duration and bone mineral density in adolescents with inherited metabolic diseases affecting the liver

    by K.YU. Rakhmanina, N.N. Taran, E.V. Pavlovskaya, I.F. Tin, M.E. Bagaeva, A.I. Zubovich, I.A. Matinyan, E.A. Kiselnikova, T.V. Strokova

    Objective. To study the association between bone mineral density (BMD) and breastfeeding duration (BFD) in adolescents with inherited metabolic diseases affecting the liver. Patients and methods. The study included 40 patients aged 14 to 19 years with inherited metabolic diseases (glycogen storage disease, Wilson’s disease and lysosomal acid lipase deficiency). BFD was assessed in months during which the child received breast milk without the introduction of infant formulas. BMD was measured in the lumbar spine using dual-energy X-ray absorptiometry. Results. A moderate positive correlation was found between BMD Z-score and BFD (rs = 0.326, p < 0.05), BMD Z-score and height Z-score (rs = 0.373, p < 0.05), and between BMD Z-score and BMI Z-score (rр = 0.387, p < 0.05). BMD Z-score was significantly higher in the group of adolescents with BFD ≥ 9 months than in the group with BFD ≤ 8 months (-0.379 ± 1.13 and -1.295 ± 1.48, p = 0.036). Conclusion. BMD values in adolescence with inherited metabolic diseases affecting the liver are higher with prolonged breastfeeding in infancy and early childhood. Key words: breastfeeding, adolescents, bone mineral density, inherited metabolic diseases

  • Experience with trientine in children with Wilson's disease: a retrospective analysis of treatment efficacy

    by M.E. Bagaeva, T.V. Strokova, A.I. Zubovich, E.V. Pavlovskaya, E.A. Kiselnikova

    The pathogenetic method of treating Wilson's disease (WD) is the prescription of copper chelators. The first-line therapy drug is D-penicillamine; if it is ineffective or causes adverse effects, trientine is prescribed. Experience with trientine therapy in Russia is limited, and we therefore consider it necessary to present our experience with the use of this drug. Objective. To evaluate the efficacy of pathogenetic therapy with trientine in children with Wilson's disease. Patients and methods. A single-center observational retrospective study included data from patients with a verified diagnosis of BV receiving therapy with trientine. Treatment was considered effective when patients achieved transaminase (alanine aminotransferase, aspartate aminotransferase) values within 1 upper limit of normal and daily copper excretion in urine of 200 to 500 μg/day. Trientine was prescribed at a dosage of 20 mg/day. The data were obtained from the patients' primary medical records – the results of examinations conducted at the clinic once every 6 months. The data collected included anamnestic, clinical, laboratory (biochemical blood and urine tests, molecular genetic tests), instrumental, and ophthalmological examination data. Results. The study included 5 patients (2 boys and 3 girls) with Wilson's disease aged 6 to 17 years. Four of the five patients had hepatic Wilson's disease, and one had mixed Wilson's disease. The median age at diagnosis of Wilson's disease was 7.5 [6.5; 8.0] years; and the median age at the start of the study was 8.0 [8.0; 14.0] years. The median duration of therapy with trientine was 5 [3.0; 7.0] years. The median time to achieve the efficacy criterion was 1.5 [1.0; 2.0] years. According to the results of ultrasound elastography of the liver, all patients showed regression of fibrosis from F2 to F0 and steatosis from S1 to S0 after 12–24 months. No side effects (allergic rashes, dyspepsia, anemia, nephropathy) were recorded in any of the children. Conclusion. Pathogenetic therapy with trientine as a second-line drug in cases of intolerance to D-penicillamine and zinc preparations is effective, as confirmed by normalization of cytolysis syndrome, daily copper excretion in urine, reduction in the degree of fibrosis and steatosis of the liver, and absence of side effects. Key words: children, Wilson's disease, chronic hepatitis, trientine, treatment

  • Clinical characteristics of Wilson’s disease in children

    by M.E. Bagaeva, A.I. Zubovich, E.V. Pavlovskaya, Moscow Russian Medical Academy Of Continuous Professional Education, I.A. Matinyan, E.A. Kiselnikova, E.L. Tumanova, N.A. Semenova, T.V. Strokova

    Wilson’s disease is an autosomal recessive disorder of copper metabolism caused by biallelic pathogenic variants in the ATP7B gene and associated with hepatic, neurological, psychiatric, and ophthalmological clinical manifestations. Objective. To determine the clinical characteristics and rates of liver cirrhosis development in children with Wilson’s disease. Patients and methods. The study included 204 children aged between 2.9 years and 17 years 11 months (boys – 99, girls – 105) with a confirmed diagnosis of Wilson’s disease. All patients underwent clinical and laboratory examinations, including clinical and biochemical blood tests, determination of daily urinary copper excretion (basal and after D-penicillamine challenge test), abdominal ultrasound, ultrasound-based liver elastography, examination by an ophthalmologist and a neurologist. Liver biopsy was performed in 72 patients. Molecular genetic blood testing was performed in 160 patients and 60 sibs. Results. The first clinical manifestations of Wilson’s disease in children were registered at the age of 7.0 [4.0;13.0] years, the age of diagnosis was 11.0 [8.5;14.0] years. Low serum levels of ceruloplasmin were recorded in 85.3% and copper in 46.2% of patients. The median daily urinary copper excretion was 122.1 [91;182] and 1608 [1145;2119] μg/day followed by D-penicillamine challenge test. According to the examination results, the hepatic form of Wilson’s disease was diagnosed in 81.4% and the mixed form in 18.6% of children. Cirrhosis developed in 29.4% of patients, with an average age of 14.0 [12.0;15.0] years. Kayser–Fleischer ring was determined in 29.9% of patients. In the ATP7B gene, the mutation NM_000053: c.3207C>A p. (His1069Gln) was detected in 77.2% at the homo- and heterozygous states. Conclusion. Early diagnosis of Wilson’s disease is crucial to prevent disease progression and the development of severe irreversible outcomes. Key words: children, Wilson’s disease, chronic hepatitis, fibrosis, liver cirrhosis

  • Ghrelin, leptin and insulin levels in underweight children

    by A.V. Keleynikova, E.V. Pavlovskaya, Moscow Russian Medical Academy Of Continuous Professional Education, N.N. Taran, I.V. Vorozhko, T.N. Korotkova, M.E. Bagaeva, A.I. Zubovich, I.F. Tin, I.A. Matinyan, et al.

    Undernutrition due to poor or selective eating is the main factor leading to underweight in children. Various hormones of the gastrointestinal tract and adipose tissue are involved in the regulation of eating behavior. A significant role is played by ghrelin and leptin, which have opposite effects on appetite. Objective. To evaluate serum levels of ghrelin, leptin and insulin in underweight children to optimize management strategies. Patients and methods. A total of 143 patients aged between 1 year and 17 years 11 months were examined. All patients were divided into two groups: study group – 65 children with underweight (median age 9 [5; 13.5] years, 34 boys and 31 girls); control group – 78 children with normal weight (median age 11 [7; 13] years, 36 boys and 42 girls). Physical development was assessed according to the WHO criteria. The level of total ghrelin was studied in patients with underweight; acyl-ghrelin, leptin and insulin were studied in both groups. Results. With increasing age of patients, there was a tendency for total ghrelin levels to decrease and leptin and insulin levels to increase. In the general group of children with underweight, the levels of acyl-ghrelin, leptin and insulin were lower compared to the control group (p < 0.05). With increasing severity of undernutrition, total ghrelin increased, whereas acyl-ghrelin and leptin decreased. Girls had higher concentrations of leptin (2.6 [1.1;7.8] ng/mL), while boys had higher concentrations of total ghrelin and acyl-ghrelin (435.8 [235.6;605.3] and 25.9 [10.6;53.2] pg/mL, respectively). Total ghrelin levels were negatively correlated with age, leptin and insulin levels; acyl-ghrelin and leptin levels were positively correlated with BMI Z-score. Conclusion. Low levels of acyl-ghrelin, leptin and insulin were recorded in patients with underweight. Further research is needed to thoroughly understand the changes in hormonal status that occur in the body during the development of undernutrition. Key words: children, anthropometry, underweight, ghrelin, leptin, insulin

  • Open Access

    Study of the role of biomarkers in determining the course of non-alcoholic fatty liver disease in children with obesity

    by A.M. Lebedeva, E.V. Pavlovskaya, M.E. Bagaeva, N.N. Taran, A.I. Zubovich, I.A. Matinyan, E.A. Kiselnikova, T.V. Strokova

    Изучение роли биомаркеров в определении характера течения неалкогольной жировой болезни печени у детей с ожирением